Bluebird Bio

10 Must-Know Biotech Stock Events to Close Out 2016
TheStreet.com
Fri, 09/9/16 - 09:04 pm
biotech
Eli Lilly
solanezumab
Biogen
aducanumab
Kite Pharma
KTE-C19
Bluebird Bio
LentiGlobin
Sarepta Therapeutics
eteplirsen
Ophthotech
Fovista
Bristol-Myers Squibb
Opdvio
Acadia
Nuplazid
Celgene
GED-301
Gilead Sciences
M&A
Bluebird bio adds a key process to pioneering gene therapy as it ramps up a pivotal PhIII
Endpoints
Thu, 09/8/16 - 06:28 pm
Bluebird Bio
gene therapy
LentiGlobin
Could Toxicity Issues Topple CAR-T Cancer Therapies?
Motley Fool
Sun, 08/28/16 - 10:09 am
CAR-T
clinical trials
Juno Therapeutics
Kite Pharma
Bluebird Bio
Ziopharma Oncology
Juno Throws Down The Multiple Myeloma Gauntlet To Bluebird
Seeking Alpha
Tue, 08/9/16 - 10:54 pm
Juno Therapeutics
Multiple Myeloma
Bluebird Bio
CAR-T
Juno strikes deal to join bluebird, Novartis in busy multiple myeloma niche
Fierce Biotech
Sat, 08/6/16 - 01:19 pm
Juno Therapeutics
Bluebird Bio
Novartis
Multiple Myeloma
BCMA
Can Bluebird Bio Fly Again?
Seeking Alpha
Wed, 05/18/16 - 11:14 am
Bluebird Bio
gene therapy
bluebird bio Inc: Catnapping in Cambridge
Motley Fool
Fri, 05/13/16 - 10:20 am
Bluebird Bio
earnings
bluebird bio, Inc. Takes Flight Towards First Approval
Motley Fool
Thu, 04/21/16 - 10:05 am
Bluebird Bio
FDA
CCALD
Lenti-D
Why bluebird bio's Stock Jumped 12.9% on Wednesday
Motley Fool
Thu, 04/7/16 - 09:39 am
Bluebird Bio
This Could Be the Next Big Pharma Buyout
Motley Fool
Sun, 04/3/16 - 10:56 am
Big Pharma
M&A
JNJ
Geron
Acadia
Jazz Pharmaceuticals
Bluebird Bio
Kite Pharma
Bluebird Bio Up As Gene Therapy Scores Against Rare Disease
Investors.com
Sat, 03/5/16 - 09:44 am
Bluebird Bio
gene therapy
Lenti-D
cerebral adrenoleukodystrophy
Celgene hitches wagon to Bluebird, doles out $10M as biotech launches 1st CAR-T trial
BioPharma Dive
Sun, 02/21/16 - 11:36 am
Celgene
Bluebird Bio
CAR-BMCA
CAR-T
Here's Why Bluebird Bio Turned in a Disappointing 2015
Motley Fool
Sat, 01/9/16 - 10:40 am
Bluebird Bio
LentiGlobin BB305
2016 Biotech Stock Prediction: It's Going to Be a Bummer Year, Folks
TheStreet.com
Thu, 01/7/16 - 01:02 pm
biotech
Celgene
biosimilars
Isis Pharmaceuticals
CAR-T
Bluebird Bio
Puma Biotechnology
MannKind
10 Biotechs Short Sellers Are Betting Against
Yahoo/Benzinga
Wed, 12/30/15 - 10:40 am
biotech
Global Blood Therapeutics
Clovis Oncology
Epizyme
Bluebird Bio
Puma Biotechnology
Tokai
MannKind
Myriad Genetics
Orexigan
KaloBios
4 Top Biotech Stocks for 2016
24/7 Wall St
Fri, 12/18/15 - 08:57 am
Roche
Amgen
Bluebird Bio
Valeant Pharmaceuticals
5 Key BioPharma Movers That Cannot Be Ignored
24/7 Wall St
Sun, 12/13/15 - 10:57 am
IMO-8400
Idera Pharmaceuticals
pracinostat
MEI Pharma
Bluebird Bio
CAR-T
Cara Therapeutics
CR845
TherapeuticsMD
TX-004HR
Bluebird Bio: Another Look At The Company After The 2015 ASH Meeting
Seeking Alpha
Fri, 12/11/15 - 10:28 pm
Bluebird Bio
Bluebird Sickle Cell Gene Therapy Falls Short of High Expectations
TheStreet.com
Sun, 12/6/15 - 11:04 am
Bluebird Bio
sickle cell disease
gene therapy
LentiGlobin
Bluebird, Celgene See Promise in T Cell Therapy for Multiple Myeloma
TheStreet.com
Sat, 12/5/15 - 12:37 pm
Bluebird Bio
Celgene
t cell therapy
Multiple Myeloma

Pages